https://www.thebodypro.com/category/efavirenz-sustiva-stocrin/tag/croi-conference-on-retroviruses-and-opportunistic-infections
Efavirenz (Sustiva, Stocrin)

CROI (Conference on Retroviruses and Opportunistic Infections)

The Latest

Dolutegravir More Effective Than Efavirenz at Achieving Viral Suppression During Late-Term Pregnancy, New Study Shows Img

Dolutegravir More Effective Than Efavirenz at Achieving Viral Suppression During Late-Term Pregnancy, New Study Shows

Unlike some previous studies that focused on early pregnancy, this study showed no associated congenital disabilities with either drug.

Efavirenz Might Decrease Effectiveness of the Vaginal Contraceptive Ring Img

Efavirenz Might Decrease Effectiveness of the Vaginal Contraceptive Ring

Efavirenz (Sustiva, Stocrin) alters hormone exposure from the vaginal ring in HIV positive women, similar or greater to that previously reported with oral hormonal contraceptives.

Unintended Pregnancies With Levonorgestrel Implant Due to Drug Interactions With Efavirenz-Based Antiretroviral Therapy Img

Unintended Pregnancies With Levonorgestrel Implant Due to Drug Interactions With Efavirenz-Based Antiretroviral Therapy

Three unintended pregnancies in women with levonorgestrel sub-dermal implants, receiving efavirenz-based antiretroviral therapy in a pharmacokinetic study, were reported in a late breaker presentation at CROI 2015.

Promo Image

Jens Lundgren, M.D., Discusses New Findings Regarding MI Risk of Specific Antiretrovirals

While at CROI 2009, I had the chance to talk with Jens Lundgren, M.D., the chief physician and director of the Copenhagen HIV Programme. Dr. Lundgren presented new data at this conference showing that specific antiretrovirals may be associated with a...